Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-958-5 | CAS number: 70865-30-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral LD50 (rat) > 2000 mg/kg bw
Dermal LD50 (rat) > 2000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June from 7th to 30th, 1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- 1987
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Manston, Kent, U.K.
- Age at study initiation: 5 to 8 weeks old
- Weight at study initiation: males 157 - 171 g; females 140 - 157 g.
- Fasting period before study: overnight fast immediately before dosing.
- Housing: animals were housed in groups of up to five by sex in solid-floor polypropylene cages with sawdust bedding.
- Diet: Rat and Mouse Expanded Diet, ad libitum.
- Water: ad libitum.
- Acclimation period: at least five days.
ENVIRONMENTAL CONDITIONS
- Temperature: 20 - 23 °C
- Humidity: 42 - 57 %
- Air changes: approximately 15 changes per hour.
- Photoperiod: 12 hours light and 12 hours darkness. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- TEST MATERIAL
- Preparation: test material was freshly prepared, as required, as a suspension at the appropriate concentration in distilled water. The concentration, homogeneity and stability of test material preparation were not determined by analysis.
- Concentration: 200 mg/ml
- Dose volume: 10 ml/kg. The volume administered to each animal was calculated according to its fasted bodyweight at the time of dosing. - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 1 male and 1 female for range-finding
5 males and 5 females for main test - Details on study design:
- RANGE-FINDING
- Duration of observation: the animals were observed for deaths or overt signs of toxicity 30 minutes, 1, 2 and 4 hours after dosing and subsequently once daily for 5 days.
- Frequency of observations and weighing: individual bodyweights were recorded on the day of dosing to allow calculation of individual treatment volumes.
- Necropsy of survivors performed: no necropsies were performed.
MAIN STUDY
- Duration of observation: the animals were observed for deaths or overt signs of toxicity 30 minutes, 1, 2 and 4 hours after dosing and subsequently once daily for 14 days.
- Frequency of observations and weighing: individual bodyweights were recorded prior to dosing on day 0 and on days 7 and 14.
- Necropsy of survivors performed: animals were killed by cervical dislocation and subiected to gross pathological examination. This consisted of an external examination and opening of the abdominal and thoracic cavities. The appearance of any macroscopic abnormalities was recorded. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- RANGE-FINDING
No deaths occurred.
MAIN STUDY
No deaths occurred. - Clinical signs:
- other: RANGE-FINDING No clinical signs of toxicity were recorded. MAIN STUDY Red-coloured diarrhoea was noted in all males and two females four hours after dosing. No other signs of systemic toxicity were noted. Red-coloured staining of the fur was noted in all
- Gross pathology:
- MAIN STUDY
No abnormalities were noted at necropsy. - Interpretation of results:
- other: not classified, according to the CLP Regulation (EC 1272/2008)
- Conclusions:
- LD50 (rat) > 2000 mg/kg bw
- Executive summary:
The study was performed to assess the acute oral toxicity of the test material in the Sprague-Dawley strain rat. The method used followed that described in the OECD guideline 401. Following a range-finding study, a group of ten fasted animals (five males and five females) was given a single oral dose of test material, as a suspension in distilled water at a dose level of 2000 mg/kg bodyweight. The animals were observed for fourteen days after the day of dosing and were then killed for gross pathological examination.
There were no deaths. Red-coloured diarrhoea was noted in all males and two females four hours after dosing. No other signs of systemic toxicity were noted. All animals showed expected gain in bodyweight during the study. No abnormalities were noted at necropsy.
Conclusion
LD50 (rat) > 2000 mg/kg bw
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: CFYstrain
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: in the weight range 252 to 281 g. - Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- TEST MATERIAL
The substance was prepared as a 75 % aqueous suspension and administered at a dogase volume of 6.7 ml/kg bw by spreading evenly over the prepared skin.
TEST SITE
- Area of exposure: on the day prior to treatment, hair was removed from the dorso-lumbar region of each rat with electric clippers. No shaving or chemical depilation was used.
- % coverage: an area equivalent to 10 % of the total body surface.
- Type of wrap if used: the treated area was covered with aluminium foil, which was held in place with "Sleek" waterproof plaster encircled firmly round the trunk.
REMOVAL OF TEST SUBSTANCE
- Washing: the treated area of skin decontaminated by washing with warm (40-50 °C) dilute soap solution, rinsing in clean warm water and finally blotting dry with absorbent paper.
- Time after start of exposure: 24 hours. - Duration of exposure:
- 24 hours
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 10 rats
- Control animals:
- yes
- Remarks:
- using water alone
- Details on study design:
- - Duration of observation period following administration: 14 days.
- Frequency of observations: treated skin were examined daily for signs of local irritation.
- Necropsy of survivors performed: all rats were sacrificed and examined macroscopically. - Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- There were no mortalities.
- Clinical signs:
- other: Slight lethargy only was observed in all animals in the 24 hours following treatment. No signs of irritation to the skin were seen during the two week observation period. Recovery of all animals, as judged by external appearance ond behaviour, was apparen
- Gross pathology:
- Autopsy findings were normal.
- Interpretation of results:
- other: not classified, according to the CLP Regulation (EC 1272/2008)
- Conclusions:
- LD50 male > 5000 mg/kg bw
- Executive summary:
Ten male rats were used to evaluate the acute dermal toxicity potential of the test item. The substance was prepared as a 75 % aqueous suspension and administered at a dogase volume of 6.7 ml/kg bw (5 g/kg bw) by spreading evenly over the prepared skin. The treated area was covered with aluminium foil, which was held in place with "Sleek" waterproof plaster encircled firmly round the trunk. After 24 hours of exposure, the treated area of skin was decontaminated by washing with warm (40-50 °C) diluted soap solution. During the observation period of 14 days, a record was kept of all signs of toxicity. All rats were sacrificed terminally and examined macroscopically. No death occurred.
Slight lethargy only was observed in all animals in the 24 hours following treatment. No signs of irritation to the skin were seen during the 2-week observation period.
Recovery of all animals, as judged by external appearance and behaviour, was apparently complete within 4 days of treatment. Autopsy findings were normal.
Conclusion
LD50 male > 5000 mg/kg bw
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
ORAL ROUTE
The acute oral toxicity potential of Acid Red 057 was investigated in two different experiments.
In the key study, performed according to the OECD guideline 401, following a range-finding study, a group of ten fasted animals (five males and five females) was given a single oral dose of test material, as a suspension in distilled water at a dose level of 2000 mg/kg bw. No deaths occurred during the experiment. Red-coloured diarrhoea was noted in all males and two females four hours after dosing. No other signs of systemic toxicity were noted. All animals showed expected gain in bodyweight during the study. No abnormalities were noted at necropsy.
The second test available confirms the studies outcomes above mentioned. The substance was prepared a an aqueous suspension and was administered by oral intubation at a dosage volume of 16.7 ml/kg bodyweight (dose of 5 g/kg bw). During the observation period of 14 days no death occurred. Signs of reaction to treatment, observed shortly after dosing, were a slight to moderate lethargy, pilo-erection, diarrhoea and diuresis. Recovery of the treated rats, as judged by external appearance and behaviour, was apparently complete within two days of treatment. Autopsy findings were normal.
DERMAL ROUTE
Ten male rats were used to evaluate the acute dermal toxicity potential of the Acid Red 057. The substance was prepared as a 75 % aqueous suspension and administered at a dosage volume of 6.7 ml/kg bw (5 g/kg bw) by spreading evenly over the prepared skin. During the observation period of 14 days, no death occurred. Slight lethargy only was observed in all animals in the 24 hours following treatment. No signs of irritation to the skin were seen during the 2-week observation period. Recovery of all animals, as judged by external appearance ond behaviour, was apparently complete within 4 days of treatment. Autopy findings were normal.
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), 3.1 Acute toxicity section, substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to a numeric criteria. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE).
The oral LD50 value was established to be greater than 2000 mg/kg, therefore test substance is out of any classification limit for acute oral toxicity (oral acute toxicity category 4: 300 < ATE ≤ 2000 mg/kg bw).
The dermal LD50 value was established to be greater than 5000 mg/kg, therefore test substance is out of any classification limit for acute dermal toxicity (dermal acute toxicity category 4: 1000 < ATE ≤ 2000 mg/kg bw).
In conclusion, test substance does not meet the criteria to be classified for oral/dermal acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.